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Chapter I 
INTRODUCTION 
In 1888 Roux and Yersin discovered diphtheria toxin. They demon­
strated that injection of sterile culture filtrates of the Klebs-Loeffler 
bacillus (Corynebacteritaa diphtheriae) into guinea pigs, rabbits, and 
pigeons produced symptoms analogous to diphtheria intoxication and late 
paralysis in man. This discovery laid the foundation for an era of search 
for means of eradicating diphtheria. Attempts were made to protect man 
by immunization with bacterial vaccines, but since these measures were 
largely unsuccessful investigations were carried out on different lines 
(Hartley, 1949)• The outcome of research in this direction was the 
announcement by Ramon (1923) that formalin-treated toxin (anatoxine or 
toxoid) could be used successfully as an immunizing agent against diph­
theria. Since then, toxoid has been employed in modified form for mass 
immunization against diphtheria in mai%r countries. 
Although vaccination with toxoid or treatment with antitoxin has 
generally proven effective (McLeod, 1943)> there are two situations 
which raise doubt as to the efficacy of these materials. The first 
concerns the carrier problem, i.e. the inability of circulating anti­
toxin to eliminate the diphtheria bacilli from the nose and throat. 
This situation arises following infection with virulent corynebacteria. 
A susceptible individual responds by developing a subclinical or clinical 
disease. In either type of illness, the infectious process produces a 
Schick-negative state and the possibility of continuous infection of the 
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nasal-pharyngeal region with accompanying discharge of organisms (Wilson 
and Miles, I964). 
A significant proportion of diphtheria convalescents continue to 
harbor specific organisms in the nose and throat up to the tenth week 
after onset of illness (Russell, 1943) or even longer (Wilson and Miles, 
1964). The importance of this is manifested in the data presented by 
Dolman and coworders (1948) in which they cite three separate outbreaks 
of diphtheria attributable to convalescent carriers. Similar evidence 
was reported by Morton (1941) and Turner (1942). 
The second point raising doubts about the efficacy of antitoxic 
immunity is the occurrence of certain uncontrolled outbreaks of diphtheria 
in communities where the population was supposedly protected. The most 
outstanding of these was the Leed's epidemic during which many cases of 
malignant diphtheria, apparently refractory to antitoxic therapy, occurred 
(Anderson et al.. 1931; McLeod, 1943)« Morton (1941), reporting on a 
diphtheria epidemic in Halifax involving some 6OO people, recorded 66 
individuals hospitalized with diphtheria who had had some degree of immunity 
as measured by a previous negative Schick test or a history of immunization 
with toxoid. Twenty-two of these cases proved fatal, even when treated 
with antitoxin. In the United States an outbreak among 125 children 
occurred in a nutrition camp in Augusta County, Virginia, where 93 percent 
of the children had previous records of immunization with alum-precipitated 
toxoid (Turner, 1942). During a severe outbreak in Baltimore in 1944, 
Eller and Frobisher (1945) noted 18 cases of "bullneck" diphtheria among 
141 school children, 64 percent of whom had county health records of 
immunization. Fourteen of these patients with "bullneck" diphtheria had 
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a history of prior inoculation. Other instances of diphtheria, sometimes 
of severe proportions, have been observed in persons who were thought to 
be reasonably protected on the basis of negative Schick tests or a history 
of immunization (Zinnemann and Zinnemann, 1939; Ipsen, 1946; Fanning, 1947; 
Dolman £t al., 1948; Edsall, 1963). In the United States where herd 
immunity is one of the highest in the Western world, there were still 444 
cases of diphtheria in 1962. In developing countries the figure is much 
higher (WHO, I964), indicating the need for renewed interest in methods 
for controlling diphtheria. 
Since most of the earlier outbreaks, particularly the one at Leeds, 
resulted from atypical strains of the gravis type. Cooper and his coworkers 
(1936) suggested that some strains of the diphtheria bacillus might be 
more invasive than others. Further evidence was put forth by Zinnemann 
and Zinnemann (1939) that the gravis strain possessed toxic or invasive 
propertiesother than the classical toxin, implying that these were associated 
with the existence of an endotoxin. 
Investigations of the endotoxic activity of diphtheria bacilli have 
been few, Rist in 1903» after extracting toxigenic diphtheria bacilli 
with alcohol and ether, obtained a fraction that was lethal to guinea 
pigs and rabbits which had been protected with large doses of antitoxic 
serum, Cruveilhier (1909) found a heat-stable substance in the diphtheria 
organisms that produced death in guinea pigs when administered intracere-
brally. The lethal effect of this material was not neutralized by addition 
of antitoxin prior to injection into animals. Similar findings were 
reported by Aviragnet et al. (1911) and Menard (1911). 
Frobisher and Parsons (1940), in more recent investigations, showed 
that intracerebral injections of atoxigenic strains of C. diphtheriae 
were lethal to mice. No difference was noted when the organisms were 
mixed with antitoxin before inoculation. Mice receiving virulent cultures 
plus antitoxin were affected in the same manner. No evidence for the 
presence of exotoxin could be observed in the avirulent strains, even 
though the method used was capable of detecting 0.00037 MLD of toxin 
(Frobisher and Parsons, 1943» Frobisher et 1947). This latter 
procedure involved testing sensitized animals (those inoculated with 
toxigenic corynebacteria) by subcutaneous injection of culture filtrates 
of the avirulent diphtheria bacillus in question. Since by this method 
as little as 0.00037 MLD toxin will stimulate an anemnestic response 
in sensitized animals, the authors were able to test for the presence of 
minute quantities of toxin in avirulent strains (Phair, 1942a). 
A search of the literature for studies of production of antibacterial 
resistance in experimental animals employing endotoxins or some bacillary 
substance other than the classical exotoxin is only slightly rewarding. 
One of the first attempts was conducted by Cruveilhier (1911) who obtained 
antibacterial sertun from goats injected intravenously first with auto-
claved suspensions of virulent Ç. diphtheriae and then with living sus­
pensions of viinlent organisms. This serum proved more successful than 
ordinary antitoxic serum in preventing vaginal and vulval diphtheria in 
guinea pigs. Hewlett (1909) triturated diphtheria bacilli in the presence 
of liquid air and sand, filtered the ground material through a sterile 
Berkefeld filter, and used the extract obtained from the filtered solution 
to protect guinea pigs against infections with living virulent organisms 
(Hewlett, 1912). He emphasized the therapeutic value of this "endotoxin" 
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in treating chronic cases and carriers of diphtheria. In a subsequent 
study conducted at Croyden Hospital in London, Hewlett and NankiveU 
(1912) demonstrated definite improvement in patients receiving one or 
more injections of endotoxin. They also showed that a majority of cases 
so treated ceased to harbor diphtheria bacilli in their nose and throat. 
Serotherapy with antitoxin had previously failed to remove the bacilli 
even though the patient had passed convalescence. Durand, in a visit to 
Park and Williams in 1920, stated that "there was less paralysis and 
attendant mortality in cases treated with diphtheria serum produced by 
the inoculation of both toxin and bacilli; i.e., an antitoxic and 
antibacterial serum, than with serum produced by use of toxin alone." 
Park and Zingher (191$), investigating the possible advantages of 
combining preparations of whole bacteria with toxin-antitoxin mixtures, 
were unable to show any increased proctection as measured by the Schick 
test. Rosenau and Bailey (1925) performed similar studies in large 
numbers of guinea pigs by giving repeated injections of live avirulent 
diphtheria bacilli for over a year. None of the animals developed a 
Schick negative state or increased immunity to a lethal dose of toxin. 
One would hardly expect, however, to detect antibacterial resistance in 
experimental subjects if they were challenged with diphtheria toxin. 
Renewed interest concerning the value of antidiphtherial vaccines 
was stimulated in part by observations of Phair (1942b) of persons with 
low or deficient circulating antitoxin who were nevertheless resistant 
to diphtheria. Phair believed that antibacterial immunity was sufficient 
to suppress, or at least delay, infection until an adequate antitoxin 
level was reached. 
Another stinailating factor was a series of reports concerning the 
association of avirulent strains of C. diphtheriae with the carrier 
state. Rosenau and Bailey (1925) recorded a greater number of isolates 
of avirulent diphtheria bacilli than of virulent organisms in a community 
in which there was a high incidence of naturally acquired resistance. 
Dudley, in 1932, showed in a study of carrier rates and latent infection 
that carriers of virulent diphtheria bacilli were 3 times greater than 
expected and were more frequently found in persons having negative Schick 
tests, Chason (1936), working in a community in which 92 percent of the 
population was Schick negative (all with negative clinical and immuniza­
tion histories), observed a greater proportion of carriers with avirulent 
strains of £. diphtheria than with virulent strains. According to 
Gill (1940), there were 0,9 percent carriers with virulent bacilli and 
3.0 percent carriers of avirulent organisms in a group of white school 
children that had a high percentage of immunity, as measured by the Schick 
reaction, regardless of whether the child had received an artificial 
immunizing agent or not. In another study Stebbins (1940) isolated 
from 3,223 individuals, of whom 33 percent were Schick negative, 42 
cultures of C. diphtheriae. only one of which proved to be virulent when 
tested in rabbits. 
These investigations prompted Frobisher and Parsons (1943) to study 
the antigenic properties of avirulent diphtheria bacilli and the 
possibility of producing antibacterial immunity against infections with 
virulent organisms. They injected relatively large doses of broth cultures 
containing live avirulent, nontoxigenic diphtheria bacilli intracutaneously, 
subcutaneously, and intravenously into 21 rabbits. When these rabbits 
mm 
were inoculated, i.e., with a live virulent culture, 4 survived and 17 
died after an average of 7 days. Control animals receiving the same 
challenge dose died in an average of 3.6 days. This degree of resistance, 
although slight, was attributed to a heightened local tissue reactivity 
which held the virulent organisms and toxin at the inoculation site, A 
subsequent investigation with a larger number of animals yielded essenti­
ally the same results (Frobisher and Updyke, 1947). 
In 1950 Frobisher and Parsons immunized guinea pigs with "Rist-
type antigens" made from virulent and avirulent strains of gpravis and 
mitis types of Ç. diphtheriae and from a virulent minimus (intermedius) 
strain. The antigens were prepared by extracting the bacilli with equal 
volumes of alcohol and ether and then shaking them with "glow beads." 
Guinea pigs immunized with these antigens were resistant to challenge 
with toxigenic organisms. The virulent mitis antigen afforded the greatest 
degree of protection. Tests performed on the Rist-type antigens with 
methods capable of detecting very small amounts of toxin (Phair, 1942a) 
were invariably negative, A followup experiment by Parsons and Frobisher 
in 1950 revealed that macerated antigens, whether extracted or not, were 
better immunizing antigens than extracted intact bacteria. 
A further study on the role of bacterial vaccines in diphtheria 
prophylaxis was undertaken by Scheibel at the State Serum Institute in 
Copenhagen (1950). Utilizing guinea pigs, she compared the immunogenic 
properties of formalin-killed virulent corynebacteria and diphtheria 
toxoid. Approximately one week after the last dose of antigen had been 
administered, all animals were challenged by placing a small quantity of 
a virulent culture in broth onto a lightly scarified area of the ventral 
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wall of the abdomen. The guinea pigs protected with toxoid survived 
without symptoms of disease. Those receiving bacterial vaccines suffered 
the same mortality rate as the controls, but survived a greater length of 
time. 
Another attempt to test the value of cellular antigens was reported 
by Bowen, %anan, and McComb (1954)» They injected heat- or chemically-
killed suspensions of C. diphtheriae or standard diphtheria toxoid 
subcutaneously into different groups of guinea pigs and then challenged 
them intradermally with both homologous and heterologous strains of 
virulent diphtheria bacilli. For the most part, their results with 
whole cell antigens confirmed the earlier studies of Frobisher. Guinea 
pigs were partially protected against challenge with the homologous strain 
of organism. However, animals immunized with toxoid were almost always 
completely resistant to infection with any of the virulent strains of £. 
diphtheriae. 
Aside from the work of these 3 groups of investigators, little has 
been reported in the literature concerning the protective antigens of 
£, diphtheriae. Alcohol-soluble lipoid substances have been extracted 
from washed cultures of organisms (Freund, 1927J Hoyle, 1942). Lipoid-
polysaccharide smd protein fractions have been described by Wong and 
T'ung (1939,1940)' Ceding (1950), Lautrop (1950), and Cummins (1954) 
demonstrated a superficial, thermolabile, specific protein and a deeper, 
thermostable group antigen which was probably a polysaccharide. Accord­
ing to Holdsworth (1952), the cell wall of G. diphtheriae consists mainly 
of a protein-polysaccharide complex with small amounts of lipids. None 
of these investigators studied the prophylactic value of these antigens. 
-9-
Instead the data was compiled in order to study the serological classifi­
cation and antigenic structure of the diphtheria bacillus. 
That protective antigens reside in the cell walls of some bacteria 
was demonstrated by the work of several investigators. A review by 
Munoz (1963) pointed out that a saline extract, prepared from acetone 
extracted and disrupted BordeteHa pertussis cells, contained the 
functional protective antigen (PA). This antigen is known to be a cell 
wall component (Munoz et al., 1959» Billaudelle ̂  al., I960) and capable 
of protecting mice against challenge with virulent B. pertussis. Krause 
(1963) showed that hemolytic streptococci disinipted by Mickle's method 
yielded cell walls which possessed the imnmnogenic characteristics of the 
cell. Investigations with Histoplasma capsulatum (Salvin and Ribi, 1955), 
Bacterium tularense (Shepard et al., 1955; Ormsbee et al., 1955), and 
species of Salmonella (Ribi and coworkers, 1958; Carey and Baron, 1958; 
Ribi et al., 1959) indicated that cell walls contained the immunogenic 
antigens of the cell and protected against experimental infection. 
Foster and Ribi (1962) demonstrated that brucellosis could be controlled 
in mice with cell-wall antigens. Recent studies by Ribi and coworkers 
(1966) have shown that pure cell walls obtained from BCG by disruption 
in a refrigerated pressure cell (Ribi et al., 1959) produced better 
resistance in mice than the standard living BCG vaccine. 
CHAPTER II 
STATEMENT OF PROBLEM 
This research was conducted in an attempt to demonstrate that cell 
walls of Corynebacterium diphtheriae could be used to induce active anti­
bacterial resistance to diphtheria in guinea pigs and rabbits. Data 
are presented to show that resistance can be developed to infections 
with virulent bacilli when one or two MLD's of organisms are used and 
that this resistance is not due to soluble toxin in the antigen or 
antitoxin in the serum of immunized rabbits. Reasons for the failure of 
antibacterial immunity are discussed. 
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CHAPTER III 
METHODS Am MATERIALS 
(1) Organisms Employed 
Four strains of Corynebacterium diphtheriae were used throughout 
this research. They were obtained from Dr, Joseph N. Schubert, Chief, 
General Bacteriological Unit, Communicable Disease Center, U. S. P. H. S., 
Atlanta, Georgia, and designated as follows; 
C. diphtheriae gravis 6O6I—toxigenic 
" mitis 6823—toxigenic 
" mitis 6795—nontoxigenic 
" intermedius 6796—toxigenic 
Since the pathogenicity of the organism is primarily dependent upon 
its ability to produce toxin, the diphtheria bacillus is more properly 
referred to as toxigenic or nontoxigenic. However, virulent and avirulent 
are occasionally used interchangeably with toxigenic and nontoxigenic 
throughout this paper. 
(2) Special Materials 
Diphtheria toxin (deep culture), 240 per ml. Lot No. 963454» and 
Formol Toxoid (deep culture concentrate), 1000 L^ per ml. Lot No, 025746-1, 
were obtained from Parke, Davis and Company through the courtesy of Dr. 
H, B, Devlin. In one phase of these studies, diphtheria antitoxin 
(equine), purchased from Davis Brothers, Missoula, Montana, was used. 
(3) Buffers, Saline Solutions, and Diluents 
A, Moloney Buffer 
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The buffer solution Moloney and Taylor (1932) was used as a diluent 
for diphtheria toxin and toxoid and was prepared as follows: a liter of 
0.10 N Sorenson's borate buffer (Hawk et al., 1962) was adjusted to pH 
8o0 with OolO N HCl, Sodium chloride and gelatin were then added to a 
final concentration of 0.8$% and 0.02% respectively. After autoclaving 
at 121 C for 15 minutes, the solution was diluted 1:4° 
B„ Tween-saline (TSS) 
A 0,85% NaCl and 0.02% Tween 80 solution was warmed gently to dissolve 
the Tween 80 prior to autoclaving. The final pH was 6.2. 
This solution without the Tween 80 was also employed and designated 
as sterile physiological saline or SS. 
C. Casamino acid diluent 
This solution was prepared by dissolving 30g Casamino Acids (Difco) 
in 1 liter of distilled water and autoclaving at 121 C for 15 minutes. 
(4) Culture Media 
Pai's medium (McGuigan and Frobisher, 1936) was prepared by beating 
375 ml whole fresh eggs and 1.06 g NaCl in 125 ml distilled water. 
Glycerol was added in a final concentration of 8% (Frobisher and Parsons, 
1950). The mixture was transferred to a beaker and thoroughly stirred, 
filtered through three layers of sterile gauze, tubed, slanted, and 
autoclaved according to the method used for heat-coagulable media (Difco, 
1963). 
Loeffler's Blood Serum slants were prepared according to the Difco 
Manual (1963)« 
Both of these media were used for routine maintenance of stock cul­
tures . 
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The chemically defined medium developed by Drew and Mueller (1952) 
and abbreviated M&M was used as the primary medium for growth of all 
strains. 
(5) Basic Solutions 
A. Amino acids and ammonium; 
1. Glycine, anhydride (Nutritional Biochemicals Corp.) -0.24 g 
2. L-glutamic, hydrochloride " -8.0 g 
3. DL-methionine " -0.27 g 
4. L-cystine " -0.4 g 
5. DL-tryptophan " -0.12 g 
6. DL-valine (Eastman Organic Chemicals) -1.2 g 
7. DL-leucine " -0.8 g 
8. L-proline " -O.I6 g 
9. (I3H/^)2 SOl (Reagent Grade) -2.4 g 
10. Distilled HgO to make -1000 ml 
L-cystine was dissolved separately in 3 niL of concentrated HCl. 
B. Accessories and Metals: 
1. -alanine (Eastman Organic Chemicals) -0.115 g 
2c Pimelic acid " -7.5 mg 
3. Nicotinic acid (Nutritional Biochemicals Corp.) -0.115 g 
4. CuSO/^ 5H2O (1^ solution) (Analytical Reagent) -5.0 ml 
5. ZnSOA 7H2O " " -4.0 ml 
6. MnCl2 4H2O " " -1.5 ml 
7. MgSO) 7H2O (Reagent Grade) -22.5 g 
8. HCl (conc) -3.0 ml 
9. Distilled H2O to make -100 ml 
Nicotinic acid was dissolved separately in 3 ml of 
concentrated HCl. 
C o Cystine : 
1. L-cystine (Nutritional Biochemicals Corp.) -20 g 
2. HCl (conc) -20 ml 
3. Distilled H2O to make -100 ml 
D, Maltose-Calcium Chloride Solution; 
1. Maltose (Difco) -50 g 
2. Calcium chloride 2H2O (Reagent) -0.5 g 
3. Distilled H^O to make -100 ml 
Fifty grams of maltose were added to 60 ml of H2O and solid 
CaClg. This was stirred, warmed gently until dissolution 
occurred, and then diluted to 100 ml with distilled H2O. 
E. Iron: 
1. FeSOjL THpO (Reagent) 
2. HCl (conc) 
3. Distilled HgO to make 
-1.0 ml 
-100 ml 
-1.0 g 
Since Pappenheimer and Johnson (1936) reported on the significance 
of adjusting the iron concentration of the medium, all solutions except 
Solution E were tested for their iron content by the method of Mueller 
and Miller (1941). A sample of each solution was boiled with HNO3 and 
the reaction mixture was then tested with KSCN and sufficient alcohol 
against Fe standards. Analysis revealed that only Solutions A and D 
contained an excess of iron. Removal of iron from these 2 solutions was 
accomplished by precipitation on calcium phosphate (Mueller and Miller, 
To prepare the medium 2.0 ml of Solution B and 1.0 ml of Solution 
C were added for every liter of Solution A. The medium was stirred 
thoroughly after each addition in order to avoid precipitation of any 
salts. A sufficient volume of Solution E was added to bring the total 
iron content to $00 gamma. This concentration allowed for satisfactory 
growth with little toxin production. Since there was a definite 
tendency towards clumping, Tween 80 (Nutritional Biochemicals Corp.) 
was added in a final concentration of 0.05% (Ward, 1948)» 
The media was then dispensed in 100 ml amounts in 1 liter Erlenmeyer 
flasks, stoppered with absorbent cotton, and sterilized for 10 minutes 
at 10 lbs in a Steroclave. When cooled, 4 ml of maltose solution, pre­
viously sterilized by Seitz filtration, was added. The pH of the final 
media was 7.6. 
1943). 
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The Mueller-Tellurite medium (Difco, 1963) described by Mueller (1946) 
was used for plating out suspensions of diphtheria bacilli. 
Agar Base 
Gasamino Acids, Technical -20 g 
Casein -5 g 
L-tryptophane -0.05 g 
KH2PO4 -0.3 g 
MgSO^ YHgO -0.1 g 
Agar -20 g 
Distilled water -1000 ml 
Semim Tellurite 
Sodium lactate (60^ Merc) -40 ml 
Ethyl alcohol -10 ml 
Calcium pantothenate -0.2 mg 
Sterile beef serum -50 ml 
The agar base was sterilized by autoclaving and cooled to 50 C. 
Just before plating, 5 ml of sterile serum tellurite was added for every 
100 ml of base. 
Beef-heart infusion agar (BHIA) was prepared according to the Difco 
Manual (1963)> except that sterile rabbit serum was added to a final 
concentration of 2^, 
(6) Maintenance of Cultures 
All the strains of Corynebacterium were maintained on slants of Pai's 
medium or Loeffler's serum and stored at 4 C. Transfers were made monthly. 
In addition, triplicate sets of vials of each strain were lyophilized and 
kept at -20 C. Periodically the cultures were examined for contamination 
by staining with Loeffler's alkaline methylene blue (LAB). 
(7) Counting Methods 
Serial 10-fold dilutions of organisms in TSS were plated after the 
method of Fenner et (1951)» Three 0.1 ml drops of each dilution were 
placed on duplicate plates of serum tellurite medium. The plates were 
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incubated at 34 C in an inverted position after the drops had dried. 
After 48 hours the colonies were enumerated with a Quebec Darkfield colony-
counter (Spencer). 
(8) Preparation of Cell Suspensions 
Cells for experiments were grown on Loeffler's seiw slants, incubated 
for I8-24 hours at 34 C, and transferred in TSS to 2-liter Erlenmeyer 
flasks, each containing lOOml of M&M media. The flasks were then 
incubated for 3 days at 34 C. After checking the purity of the cultures 
with LAB, a 5 nil inocula was transferred to the desired number of fresh 
flasks of MScM media. These were incubated for 48 hours in the 34 C in­
cubator prior to the harvest of the bacilli. 
For experimental procedures, cells grown in M&M media for 48 hours 
were collected in 250 ml Nalgene antigen bottles and centrifuged at 
22,000 G for 30 minutes in a Sorval Refrigerated Centrifuge (RC-2). 
The packed cell mass was re suspended in TSS and filtered through Whatman 
#4 filter paper in a Éuchner funnel. The suspension of cells was diluted 
with TSS to an appropriate concentration on the basis of their turbidity 
in a Klett Summerson photoelectric colorimeter fitted with a #42 blue 
filter. 
(9) Disintegration of Bacteria and Preparation of Cell Wall Material 
The procedure described by Cummins (1954) was used to disrupt Cory-
nebacterium in the Mickle Tissue Disintegrator. Cells harvested from 
M&M media were initially stained for purity, then poured into 250 ml 
antigen bottles and centrifuged for 30 minutes at 22,000 G in the RC-2. 
The supernatant was discarded but the cells were washed twice with sterile 
distilled water. Approximately 5OO mg wet weight of washed bacilli were 
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deposited in 8 ml of cold distilled water. This suspension was added to 
a cold Mickle tube containing 4 g of #12 Cataphote glass beads. A single 
layer of celophane was placed around the inibber stopper to prevent con­
tamination with small particles of rubber. Disiniption was carried out in 
the cold for 2 hours, at which time only an occasional Grajn positive cell 
was visible in a smear. A 10 C rise in temperature was noted. 
When shaking was completed, the supernatant was pipetted from the 
glass beads and placed into a 40 ml plastic centrifuge tube. The beads 
were washed twice with 1-2 ml volumes of sterile distilled water. These 
washings were added to the supernatant, and the combined cell wall 
suspension was centrifuged for 2 hours at 27,000 G in the RC-2. Follow­
ing this initial centrifugation, the supernatant, or protoplasm, was 
decanted from the packed cell walls and stored at 4 C for later use. 
The cell walls were washed 4 times in sterile distilled water with 
centrifugation at 27,000 G after each washing. The final suspension of 
cell walls was lyophilized and stored at -20 C. 
Prior to use, the cell walls were weighed on an analytical balance 
and the desired amount suspended in O.A$ formalin. The suspension was 
refrigerated overnight at 4 C, then checked for sterility by plating of 
undiluted and 1:10 dilutions of the suspension on serum tellurite medium. 
(10) In Vitro tests for Antigen-Antibody Determinations 
Agglutination reactions; Twenty-four hour cultures of organisms 
grown on BHIA-2% serum slants were suspended with TSS and centrifuged at 
22,000 G for 10 minutes. The packed cells were resuspended in a few mis 
of TSS and heated at 60 C for one hour. Since diphtheria bacilli had 
a tendency to clump spontaneously, the heat-killed cells were filtered 
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through Whatman #4 filter paper just prior to use. The filtrate was 
diluted to the Francis Standard of approximately 3 nig dry weight/ml. 
The agglutination reactions were carried out on Perspex agglutination 
trays (instruments Association Inc.). Six-tenth ml of a 1:5 dilution of 
the serum under test was placed in the first cup of the row and 0.3 ml 
sterile saline in each of the remaining cups. A serial 2-fold dilution 
was made by transferring 0.3 ml of the serum dilution with 0.5 ml pipettes. 
Saline and normal rabbit sera were used as controls. To each dilution 
an equal volume (0.3 ml) of cell suspension was added. The trays were 
covered with Saran Wrap to prevent evaporation and placed in a 37 C 
incubator for 2 hours followed by overnight refrigeration at 4 G. The 
highest dilution showing a positive reaction was considered as the titer 
of that serum. 
Precipitin reactions; Protoplasm was titrated in the same manner as 
the antiserum in the agglutination test, except that the initial dilution 
was undiluted (10 mg/ml, dry weight). A capillary precipitation test 
was performed by layering the diluted antigens (protoplasm) on top of 
the antiserum. A positive reaction was recorded by a precipitation at 
the interface of antigen and antibody after incubating at 37 C for 1 hour 
and 4 C overnight. 
Ramon flocculation experiments were also conducted. Serial 2-fold 
titrations of antiserum (0,5 ml) were mixed with a constant amount of 
protoplasm (5 mg/ml, dry weight) or diphtheria toxin (1, 2, 5, 10, or 
20 L^/ml). The reaction mixtures were placed in a 50 C water bath and 
observed at frequent intervals to determine the tube containing an 
optimal proportion of antigen and antibody. 
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(11) Schick Testing 
Diphtheria toxin was diluted in Moloney buffer to 0.00004 per 
0.2 ml. This constituted 1 Schick test dose (STD). Animals to be 
tested received 0.2 ml of an unheated and a heated (70 C for 15 minutes) 
STD intradermally. Reactions were measured at the end of l^B hours with 
a metric ruler and a Schnelltester (System KrSplin). 
(12) Test for Presence of 0.001 Unit of Antitoxin 
This procedure was modified from the method developed by Fraser 
(Frobisher, 1950). Dilutions of test serum in 1 ml amounts were mixed 
with an equal volume of standardized toxin, incubated at 37 C for 1 hour, 
and then stored overnight at 4 C. Normal rabbit serum (MRS) and antitoxin 
diluted to contain 0.001 unit were substituted for the test serum in the 
controls. Two-tenth ml of each dilution was injected intracutaneously 
into the shaven side of normal guinea pigs. After 48 hours the reactions 
were measured and recorded in mm. For purposes of this research, a reaction 
greater than 9x9 mm in diameter produced with test serum and toxin mixture 
was rated as negative for 0.001 unit of antitoxin. 
(13) Animals 
Guinea pigs of the Hartley strain purchased from R. C. Rosencranz, 
Hamilton, Montana, were used. These animals weighed 275 to 350 g when 
immunized and were 4 to 5 weeks old. Albino rabbits of both sexes, 
purchased from L. VanGilder, Missoula, Montana or John's Rabbitry, Spokane, 
Washington, and weighing 1.8-2.7 kg, were employed. 
CHAPTER IV 
EXPERIMENTAL PROCEDURES AND RESULTS 
Experiment 1. Titration of toxigenic Corynebacterlim in the skin of 
rabbits. The procedure for titrating the virulent strains of Corynebacteriiun. 
was modelled after the method of Larson et al. (i960). Toxigenic strains 
were harvested from 3-day cultures of MScM media and prepared as previously 
described. After filtering, the cell suspension was adjusted to various 
turbidity readings on the colorimeter and plated on serum tellurite 
medium. For preliminary titrations the adjusted suspensions were diluted 
in 10-fold increments, but in the final titration, 2-fold serial dilutions 
were used. Two-tenth ml of each dilution was injected intracutaneously 
into the shaven, lateral side of 3 rabbits. All dilutions were made in 
TSS, The course of the skin reactions was followed at intervals of 24, 
48, 72, 96 hours. The measurements of the lesions were recorded in mm; 
the degree of edema being determined with a Schnelltester. Any reaction 
less than 5x5 mm in diameter and 0.3 in thickness was termed a 
flush (fl). 
When selected 10-fold dilutions of the toxigenic strains were 
titrated in the skin of normal rabbits, it appeared that between 500 and 
5^000 organisms were required to produce a lesion. Therefore, 2-fold 
serial dilutions of organisms were made and adjusted to contain approx­
imately 500 viable units in the final dilution. Tables I, II, and III 
show the skin reactions observed during a period of 4 days following 
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Table I: Dermal reactivity in rabbits produced by intradermal inoculation 
of toxigenic Corynebacterium diphtheriae mitis strain 6823. 
Babbit 
No. 
Time of 
reading 
Cutaneous reaction 
dose, xlCr viabZ 
in mm at indicated 
Le units 
(hrs.) 32 16 8 4 2 1 
A 24 I6xl6* 
1.3^ 
15x13 
0.6 
14x12 
0.3 
10x12 
0,2 
fl. — 
48 16x17 
1.4 
lipcl3 
0.8 
11x10 
0.7 
8x6 
0.5 
fl. —— 
72 16x17 
1.1 
13x12 
0.7 
10x10 
0.7 
7x6 
0.4 
fl. 
96 15x14 
1.2 
11x11 
0.7 
9x8 
0.6 
5x4 
0.2 
fl. — 
B 24 18x17 
1.5 
14x13 
0.7 
13x12 
0.4 
11x10 
0.5 
fl. "• 
48 17x16 
2.0 
12x11 
1.1 
11x9 
0.8 
7x7 
0.5 
fl. 
72 16x14 
1.6 
12x11 
0.8 
10x9 
0.7 
8x7 
0.4 
fl. 
96 15x14 
1.5 
10x10 
0.8 
9x9 
0,7 
6x6 
0.3 
fl. — 
C 24 16x14 
1,4 
10x11 
0.5 
2x8 
0.3 
6x7 
0.2 
fl. — 
48 16x15 
1.9 
12x13 
1.1 
8x7 
0.6 
5x6 
0,4 
fl. 
72 14x13 
1.5 
11x11 
0.9 
7x7 
0.5 
5x4 
0.2 
fl. — 
96 13x13 
1.5 
9x9 
0.8 
5x6 
0.4 
fl. fl. — 
•K" diameter of lesion 
thickness of lesion 
Table II; Dermal reactivity in rabbits produced by intradermal inoculation 
of toxigenic Corynebacterium diphtheriae gravis strain 6O6I. 
Rabbit 
No. 
Time of 
reading 
(hrs.) 
Cutaneous reaction in mm at indicated 
dose, xlCK viable units 
40 20 10 5 2.5 1.25 0.625 
A 24 17x18* 
1.9** 
16x14 
1.5 
12x11 
0.8 
8x9 
0.3 
7x7 
0.2 
fl. — 
48 20x18 
3ol 
16x15 
2.1 
13x12 
1.3 
9x11 
0.8 
6x7 
0.5 
fl. 
72 16x15 
3.0 
14x13 
1.6 
12x11 
1.3 
9x8 
0.6 
8x7 
0.3 
fl. —— 
96 14x14 
2,2 
13x14 
1.2 
9x10 
0.9 
8x8 
0.5 
6x7 
0.3 
fl. — 
B 24 21x19 
2.0 
18x14 
1.5 
16x13 
1.1 
9x10 
0.3 
7x8 
0.2 
fl. 
48 23x20 
3.4 
2]jcl3 
2.3 
16x12 
1.5 
10x10 
1.1 
7x9 
0.5 
fl. 
72 18x16 
2.7 
15x12 
1.4 
13x11 
1.3 
8x8 
0.8 
8x7 
0.6 
fl. 
96 17x16 
2.8 
13x13 
1.3 
13x12 
1.0 
7x9 
0.7 
7x7 
0.4 
fl. 
C 24 22x22 
2.6 
19x15 
2.0 
15x13 
0.7 
10x9 
0.6 
8x9 
0.2 
fl. — 
48 28x25 
3.3 
20x17 
2.4 
15x15 
1.3 
11x10 
0.7 
8x9 
0.5 
fl. —— 
72 23x32 
3.1 
21x18 
2.1 
14x12 
1,4 
10x8 
0.8 
8x7 
0.4 
fl. — 
96 20x18 
2.6 
20x15 
1.7 
12x12 
1.3 
7x8 
0.7 
7x5 
0.4 
fl. —— 
* diameter of lesion 
thickness of lesion 
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Table III: Dermal reactivity in rabbits produced by intradermal inoculation 
of toxigenic Corynebacterium dlphtheriae intermedius strain 6796. 
Rabbit 
No. 
Time of 
reading 
(hrs.) 
Cutaneous reactions in mm at indicated 
dose, xICk viable units 
40 20 10 5 2,5 1.25 0.625 
A 24 24x18^ 
1.9^-^ 
16x15 
1,2 
14x11 
0.7 
10x10 
0,5 
6x9 
0,2 
fl. — 
48 22x20 
2,4 
17x13 
1.6 
15x13 
1.1 
10x8 
0.7 
7x9 
0.5 
fl. — 
72 21x19 
2.0 
16x13 
1.2 
14x12 
1.1 
8x7 
0,6 
6x7 
0.4 
fl. — 
96 20x19 
1.8 
15x11 
1.1 
12x12 
0.7 
6x6 
0.4 
5x4 
0.3 
fl. —— 
B 24 17x18 
1.2 
14x9 
0,8 
10x9 
0.5 
7x7 
0.3 
4x7 
0.2 
fl. — 
48 20x16 
1.7 
16x10 
1.3 
14x12 
1.2 
8x10 
0.7 
5x5 
0.4 
fl. 
72 17x15 
1.5 
15x11 
1.2 
13x12 
0,9 
6x7 
0,5 
5x6 
0,2 
fl. —— 
96 I6xl6 
1.4 
15x10 
1.0 
11x11 
0.8 
6x6 
0.5 
fl. fl. 
C 24 12x13 
1.0 
12x12 
0.9 
9x9 
0.7 
6x6 
0.2 
8x5 
0.2 
fl. — 
48 12x15 
1.4 
11x11 
1,2 
10x8 
1.0 
8x8 
0,7 
7x5 
0.4 
fl. 
72 11x12 
1.3 
10x8 
0,7 
9x9 
0,6 
7x6 
0.4 
fl. fl. 
96 11x9 
1,0 
10x7 
0,8 
9x8 
0,6 
5x5 
0,2 
fl. fl. 
^ diameter of lesion 
•JB5- thickness of lesion 
—24-" 
injection of a series of 2-fold dilutions of toxigenic mitis, gravis. and 
intermedius organisms into the skin of 3 rabbits. At 24 hours the lesion 
was represented by a diffuse erythema and edema, which was not easily 
measured with the Schnelltester due to the softness of the lesion. Much 
more defined lesions were apparent at 48 hours, and the degree of edema 
was read without difficulty. The reactions had progressed no further 
whefi measured at 72 hours and were showing evidence of healing. The 
lesions were dark or purplish. At the site where the highest concentra­
tion of bacilli had been injected, central necrosis was evident. During 
the next few days there was a decrease in the size of the lesions, and 
by the seventh or eighth day only slight indications of dermal reaction 
remained. 
These results indicate that the height of the inflammatory response 
occurred 48 hours after injection of toxigenic organisms. Moreover, the 
number of organisms required to produce a dermal reaction was about the 
same for the 3 strains. 
Experiment 2. Immunization with cell walls incorporated in complete 
Freund's adjuvant. This preliminary experiment was designed to determine 
the ability of diphtheriae cell walls in complete Freund's adjuvant to 
evoke an immunogenic response in rabbits. The adjuvant was prepared by 
grinding simultaneously Arlacel A (Atlas Chemical Company) and sufficient 
tubercle bacilli (acetone-dried BCG) to give 1 mg per dose. To this was 
added nine parts light mineral oil (Pharmaceutical Laboratories). An 
equal volume of formalin-sterilized cell wall material was then slowly 
added to the oil mixture to form a fine emulsion. Eight rabbits were 
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divided into 2 groups of 4 each; group I received the cell wall antigen 
and group II served as controls. Prior to injection of the antigen, a 
20 ml sample of blood was collected from each animal» The rabbits in 
group I each received 4 subcutaneous injections of 1 ml cell wall-adjuvant 
mixture, 1 in each inguinal and axillary region. This amounted to 1 mg 
of tubercle bacilli and 0.5 mg of cell walls per injection site, or a 
total of 2 mg cell wall material per animal. Booster injections were 
given subcutaneously in the nuchal region at the end of the fifth and 
sixth weeks. Each dose contained 0.5 mg of cell walls diluted in 0.5 ml 
saline. 
Starting on the 14th day after the initial immunizing dose, weekly 
samples of blood were collected from the marginal ear vein of each rabbit. 
In addition to determining the level of antitoxin, the serum agglutinin 
and precipitin titers were determined. During the ninth week, all rabbits 
were Schick tested and challenged by intracutaneous injection of a series 
of dilutions of toxigenic C_̂  diphtheriae mit is strain 6823 and a sus­
pension of heat-killed organisms (70 C for 15 minutes). All skin reactions 
were recorded as described in the initial experiment. 
The ability of cell walls to stimulate the formation of agglutin­
ating antibodies against whole cells of toxigenic mitis is shown in Fig. 
1. Although the serum titers varied in the different animals, there was 
a progressive increase until the sixth week when the antibody titer began 
to decrease. The agglutinin titers against heterologous toxigenic strains 
were somewhat lower (Fig, 2). 
None of the sera contained precipitins against homologous or hetero­
logous protoplasm at any dilution. Ramon tests were negative. In 
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Figure 1: Serum agglutination titers to heat-killed Corynebacterium 
diphtheriae mitis strain 6823 in rabbits immunized with cell walls 
of the same strain. 
2 mg. in Freund's adjuvant 
5120-
0.5 mg. in saline 
2560-
1280 
•H 640 
320-
160 
80-
40-
serum #864 
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-r 
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nr 
5 8 
Time of bleeding (weeks) 
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Figure 2: Mean serum agglutinin titers to heat-killed mitis 6823, gravis 
606l, and intermedius 6796 strains of Corynebacterixim diphtheriae in 
rabbits immunized subcutaneously with cell walls of diphtheriae mitis. 
2 mg. in Freund's adjuvant 
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2560-
1280 
64a 
320-
160-
80 
40-
0.5 mg, in saline 
I i 
anti-mitis antibodies 
-X anti-gravis antibodies 
-© anti-intermedius antibodies 
-| 1 1 1 1 1 1 1 r 
1 2 3 4 5 6 7 8 9  
Time of bleeding (weeks) 
addition, no antitoxin was detected at the 0.001 level or by the Schick 
test (Table V). These data, therefore, suggest that cell walls contain 
very little, if any, toxin, and that the greater part of any resistance 
would have to be of an antibacterial nature. 
The results of the intradermal challenge appear in Table IV. The 
development of dermal reactions in the immunized animals follows the same 
pattern as in the control rabbit (see also Table I) with the height of 
inflammatory response occurring at 4̂  hours. However, the intensity of 
the inflammatory responses in the immunized animals was considerably 
less than in the control rabbit. Whereas the control animal reacted to 
3.0x10̂  viable units, none of the immunized animals showed a reaction at 
this dilution (a 4-fold difference). 
The delayed reactions to heat-killed organisms are listed in Table V. 
All the experimental animals demonstrated some delayed response, presum­
ably directed toward the cells since heated toxin elicited no response. 
The results of Tables IV and V suggest that the reactions to live 
organisms might in great part be delayed reactions against cell walls. 
Experiment 3» Neutralizing ability of specific immune serum. In 
order to determine if delayed hypersensitivity had masked the immune 
response of the animals in Experiment 2, immune serums from 2 of the 
animals were tested for their ability to neutralize toxigenic mitis 
organisms prior to injection into animals. A suspension of toxigenic 
G. diphtheriae mitis was prepared in the usual manner. Sera employed 
were from rabbits in Experiment 2 and consisted of normal serum from 
rabbit 8671 Immune sera from rabbits 869 and 870 bled 6 weeks after 
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Table IV: Skin reactions in rabbits iramunized with cell walls of Coryne-
bacterium diphtheriae mitis strain 6823 in Freund's complete adjuvant and 
challenged 9 weeks later by intradermal inoculation of toxigenic Coryne-
bacterium diphtheriae mitis strain 6823. 
Rabbit 
No. 
Immunizing 
dose 
Time 
measured 
(days) 
Cutaneous reactions in mm at indicated 
dose, xlCr viable units 
48 12 3 0.75 
864 3 mg, subcu* 1 
2 
3 
4 
7x5x0.6 
9x8x0 o 9 
9x8x0.8 
8x8x0.4 
fl. 
4x5x0.5 
5x5x0.3 
4x5x0.2 
— 
869 Î!  1 
2 
3 
4 
10x9x0.8 
9x8x0.9 
8x8x0.9 
7x7x0.5 
5x5x0.2 
5x5x0.4 
5x5x0.4 
5x4x0.3 
— 
— 
870 M 1 
2 
3 
4 
5x6x0.3 
7x7x0.7 
4x5x0.4 
fl. 
fl. 
fl. 
fl. 
fl. 
-
871 tl  1 
2 
3 
4 
5x5x0.4 
8x8x0.9 
8x8x0.9 
6x7x0.7 
fl. 
5x6x0.4 
5x6x0.4 
5x6x0.3 
— — 
867 Control*# 1 
2 
3 
4 
10x11x1.8 
17x28x3.5 
13x13x2.0 
12x13x1.6 
7x6x0.5 
13x15x1,7 
9x9x1.2 
9x9x0.8 
fl. 
fl. 
fl, 
fl. 
— 
* Immunizing dose, 2 mg cell wall material (dry weight) in Freund's 
complete adjuvant and 1 mg in 2 booster doses separated by one week, 
iMc 3 other control rabbits died of an intercurrent infection, but compare 
with Table I. 
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Table V: Delayed reactions to heat-killed Corynebacterium diphtheriae 
mitis strain 6823 or diphtheria toxin in rabbits immunized with cell 
walls of Corynebacterium diphtheriae mitis strain 6823 in Freund's 
complete adjuvant. 
Rabbit Immunizing 48-hour cutaneous reactions in mm 
No. dose Heat-killed org.xlÔ  Schick test (toxin 
19.2 4.8 1.2 0.3 0.075 Unheated Heated 
864 3 mg, subcu 5.5 
0,5 
5.4 
0.3 
fl. 15x11 
0.2 
— 
869 II 10x10 
1.1 
7x8 
0.7 
6%? 
0.6 
3x4 
0.4 
fl. 8x9 
0.2 
— 
870 II 5x5 
0.3 
fl. fl. 12x11 
0.2 
-
871 II 6x5 
0.4 
5x6 
0.4 
4x4 
0.3 
fl. — 13x13 
0,4 
— 
867 control* — — — 12x13 
0.3 
« 
* 3 other rabbits succumbed to an intercurrent infection 
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initial injection of antigen» Each immune serum had an agglutination 
titer of 5120 against toxigenic mitis. Serum HF-1 was obtained from a 
rabbit that had received 2 mg of cell walls in Freund's adjuvant subcu-
taneously and 3 weekly injections of 0.5 mg cell walls intravenously. 
This serum had an agglutination titer of 20,480 against toxigenic mitis. 
After equal volumes of diluted serums and serial 2-fold dilutions of 
mitis suspension were mixed and incubated at room temperature for 1 hour, 
0.2 ml of each dilution was injected intradermally into the sides of 2 
normal rabbits. The skin reactions observed at IS hours are shown in 
Table VI. The data show that specific immune sera, 869 and 870, neutral­
ized the toxigenic mitis strain approximately 4-fold in comparison with 
the normal serum. The HF-1 serum neutralized the toxigenic strain to a 
greater extent. By comparing the ability of sera from rabbits 869 and 
870 to neutralize vitro the effects of intradermal injection of 
toxigenic mitis organisms and the ability of these rabbits to neutralize 
the same organisms jg vivo (Table I?), it appeared that the results of 
the vivo test represented neutralization of toxigenic activity and 
were not influenced entirely by delayed hypersensitivity. It is 
difficult, however, in view of Frobisher's studies (1943)> to minimize 
the value of a heightened tissue response against the mitis organisms. 
Experiment 4» Comparative protection against toxigenic mitis. gravis, 
and intemedius strains. In this experiment 24 rabbits were divided into 
4 groups of 6 each. The animals in groups I and II were immunized with 
cell wall antigensJ the former received cell walls of the atoxigenic mitis 
strain, the latter, cell walls of the toxigenic mitis strain. These were 
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Table Vis Ability of specific immune serum to neutralize Corynebacteritm 
diphtheriae mitis strain 6823 » 
Serum Agglutination titer against 
mitis 6823 
!4.8-hour skin reactions in mm at indicated dose, xl( 
No, 54 27 13.5 6,8 3.4 1.7 0.85 
Rabbil b no, D 
HRS negative 20x22 
2.5 
18x14 
2,0 
15x10 
1,1 
9x7 
0.8 
6x7 
0,5 
fl. — 
869 5120 16x14 
1.8 
11x12 
0.9 
6x7 
0,6 
fl. — -
870 5120 17x13 
1,8 
9x10 
1.0 
7x7 
0,6 
fl. - -
HF-1 20,480 12x14 
1.0 
7x8 
0.7 
fl. 
Eabb: it no, I : 
NES negative 20x18 
2,1 
15x14 
1.8 
13x11 
1.2 
9x10 
0.7 
5x5 
0,4 
fl. -
869 5120 14x15 
1.3 
10x10 
0,9 
8x6 
0.5 
fl. — — 
870 5120 13x12 
1.5 
10x11 
0,8 
5x6 
0,4 
fl. — o. 
HF-1 20,480 11x12 
0,9 
7x7 
0,6 
fl. 
' 
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administered intravenously in the marginal ear vein according to the 
following schedules 
Dose/0<,5 ml and day injected 
Week Monday i-riday 
1 0.1 mg 0.2 mg 
2 0.2 0.3 
3 0.3 0.4 
Total of 1.5 mg/rabbit 
The rabbits in group III were given a human dose of Formol Toxoid (FT). 
This consisted of 2 subcutaneous injections of 2$ in 0.5 ml each, 
1 during Monday of the first week and the other on Monday of the third 
week. The last group of animals served as the normal controls (group 
IV). All the experimental and control animals were bled the same day 
(7 days after receiving the last immunizing injection). The level of 
antitoxin and serum agglutinin and precipitin titers were determined. 
One week after the last immunizing injection, each of the rabbits 
was Schick tested and challenged intradermally with titrated toxigenic 
mitis 0 gravis, and Intermedius. Since they could not all be conven­
iently tested on the same day, the rabbits were challenged over a period 
of 3 days. The results appear in Tables VII through XIV, and each table 
contains results following challenge with a single strain of organism.* 
The rabbits immunized with toxoid demonstrated a greater degree of resis­
tance against all 3 challenge strains than did animals of either of the 
groups immunized with cell walls. In the latter groups (with the exception 
* The last group of rabbits lacked suitable skin area for challenge with 
C. diphtheriae intermedius strain 6796, 
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Table VII: Skin reactions in rabbits protected with cell walls of 
Gorynebacteriim diphtheriae mitis strain 6823 (toxigenic) or 6795 
(nontoxigenic) or with Formol Toxoid, and challenged 28 days after 
the primary injection by intradermal inoculation of toxigenic 
Corynebacterium diphtheriae mitis strain 6823. 
Rabbit 
No. 
Immunizing 
antigen 
48-hour cutaneous reaç 
dose, xlO' 
jtion in mm at indicated 
v.u./dose 
44 22 11 5.5 2.75 1.38 
1631 6823 C.W.* 6x6 
0.3 
fl. fl. - - — 
1624 6795 C.W.* 12x12 
0.9 
8x6 
0.5 
7x5 
0.3 
fl. -
1588 Toxoid̂ t# fl. — — 
1662 Control 14x15 
1.6 
12x10 
1.0 
6x6 
0.4 
4x5 
0.3 
fl. 
* Dmmmizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
Human dose, 50 Lf Form.ol Toxoid given subcutaneously. 
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Table VHI: Skin reactions in rabbits protected with cell walls of 
Gorynebacterlum diphtheriae mitis strains 6823 (toxigenic) or 6795 
(nontoxigenic) or with Formol Toxoid, and challenged 28 days after 
the priiuary injection by intradermal inoculation of toxigenic Coryne' 
bacterium diphtheriae gravis strain 6o6l. 
Babbit 
No, 
Immunizing 
antigen 
48-hour cutaneous reactions in mm at : 
dose, xlCr v.u./dose 
indicated 
52 26 13 6,5 3.3 1.6 0.( 
1631 6823 C.W.* 7%7 6x5 5x6 5x5 5x3 fl. 
0.8 0.8 0,7 0,2 0,2 
1624 6795 C.W.# 9x10 9x8 7x7 5x4 fl. 
1.3 0,8 0,5 0,3 
1588 Toxoid"** fl. fl. fl. fl. - -
1662 Control 20x21 15x13 11x11 11x9 8x8 6x7 fl. 
2.0 1,5 1,1 0.9 0.4 0.2 
Immunizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
•s* Human dose, 50 given subcutaneously. 
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Table IX: Skin reactions in rabbits protected with cell walls of 
Corynebacteriim diphtheriae mitis strain 6823 (toxigenic) or 6795 
(nontoxigenic)or with Formol Toxoid, and challenged 28 days after 
the primary injection by intradermal inoculation of toxigenic 
Corynebacterium diphtheriae intermedius strain 6796. 
Rabbit 
No. 
Immunizing 
antigen 
48-hour cutaneous rea 
dose, xlCr 
ction in 
v.u. 
. mm at indicated 
50 25 12.5 6,25 3.13 1.6 
1631 6823 C.W.# fl. fl. — - -
1624 6795 C.W.* 5x5 5x6 5x4 fl. 
0.3 0,3 0.2 
1588 Toxoid-K# — — — — 
1662 Control 9x9 8x9 8x7 5x6 fl. 
0.6 0.4 0.4 0,2 
* Immunizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
•3B5- Human dose, 50 Lf Formol Toxoid given subcutaneously. 
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Table Xt Skin reactions in rabbits protected with cell walls of 
Corynebacteriip. diphtheriae mitis strains 6823 (toxigenic) or 6795 
(nontoxigenic)or with Formol Toxoid and challenged 29 days after 
the primary injection by intradermal inociilation of toxigenic 
Corynebacteriim diphtheriae mitis strain 6823. 
Eabbit 
No. 
Immunizing 
antigen 
48-hour cutaneous reactions in mm at 
dose, xlO"̂  v.u./dose 
indicated 
50 25 12.5 6.25 3.1 1.6 0.8 
1633 6823 c.w.̂  7x7 
0.5 
6x6 
0.4 
5x5 
0.3 
fl. — - — 
1634 IÎ 12x11 
0.8 
8x8 
0.6 
5x5 
0.3 
fl. CM. - -
1627 6795 c.w.̂ - 13x15 
1.2 
11x12 
1.0 
9x10 
0.4 
fl. — — -
1629 II 11x10 
0.7 
7x7 
0.4 
6x5 
0,4 
5x5 
0.3 
fl. — — 
1589 Toxoid"*# fl. fl. a. — — 
1590 II fl. fl. fl. fl. - -
1594 Control 13x13 
1.3 
%c9 
0.8 
7x7 
0.6 
6x7 
0.5 
5x5 
0.4 
fl. 
1660 II 15x14 
1.0 
9x9 
0.8 
7x6 
0.6 
6x5 
0,4 
4x5 
0.3 
fl. — 
* Immnizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
•5HS- Human dose, 50 Formol Toxoid given subcutaneously. 
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Table XI: Skin reactions in rabbits protected with cell walls of 
Corynebacterium diphtheriae mitis strains 6823 (toxigenic) or 6795 
(nontoxigenic)or with Formol Toxoid and challenged 29 days after 
the primary injection by intradermal inoculation of toxigenic 
Corynebacterium diphtheriae gravis strain 6o6l. 
Babbit 
No. 
Immunizing 
antigen 
48-hour cutaneous reactions in ram at 
dose, xlÔ  v.u./dose 
indicated 
48 24 12 6 3 1.5 0.75 
1633 6823 C.W.* 20x20 
1.5 
12x12 
1.0 
10x10 
0.9 
9x10 
0.7 
5x5 
0.3 
fl. -
1634 tl 14x15 
1.0 
13x14 
0.9 
11x10 
0.8 
10x10 
0.6 
5x5 
0.3 
fl. — 
1627 6795 C.W.* 18x17 
2.1 
16x15 
1.6 
9x8 
0.8 
8x8 
0.3 
fl. — — 
1629 !! 20x21 
4.0 
15x13 
3.0 
14x12 
1.3 
11x11 
1.1 
I]jcl3 
1.0 
8x8 
0.4 
fl. 
1589 Toxoid#* 9x9 
0.3 
5x6 
0.2 
fl. - - — — 
1590 M fl. fl. fl. fl. — — 
1594 Control 25x30 
3.0 
14x14 
1.7 
12x11 
1.2 
11x10 
0.9 
9x8 
0.4 
7x5 
0,3 
fl. 
1660 I I  22x22 
2.3 
15x12 
1.3 
11x11 
1.0 
10x10 
0.8 
6x7 
0.5 
6x6 
0.3 
fl. 
* Imniunizing dose was 1.5 mg ceH wall material (dry weight) 
given intravenously. 
•w Human dose, 50 Formol Toxoid given subcutaneously. 
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Table XII; Skin reaction in rabbits protected with cell walls of 
Corynebacterim diphtheriae mitis strain 6823 (toxigenic) or 6795 
(nontoxigenic) or with Formol Toxoid and challenged 29 days after 
the primary injection by intradermal inociilation of toxigenic 
Gorynebacterium diphtheriae intermedins strain 6796. 
Rabbit 
No. 
Immunizing 
antigen 
48-hour cutaneous reactions in mm at indicated 
dose, xlÔ  v.u./dose 
38 19 9.5 4.75 2.38 1.19 0.59< 
1633 6823 c.w.̂ - Uxll 
1.1 
8x7 
0.6 
6x6 
0.4 
fl. - — — 
1634 !} 13x14 
1.1 
12x12 
0.7 
10x9 
0.4 
7x6 
0.3 
fl. — — 
1627 6795 C.W.* 16x18 
2.0 
14x16 
1.2 
10x9 
0.4 
fl. — — -
1629 II 12x11 
1.2 
8x8 
1.0 
6x6 
0.6 
5x6 
0.4 
fl. - -
1589 Toxoid-K* fl. fl. - — — -
1590 II fl. fl. fl. - - -
1594 Control 14x13 
1.4 
12x12 
1.2 
10x7 
0.9 
6x8 
0.5 
5x6 
0.3 
fl. -
1660 II 17x21 
1.7 
13x15 
1.0 
10x9 
0.8 
7x8 
0.4 
5x4 
0.3 
fl. -
* Immunizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
Human dose, 50 Lj Formol Toxoid given sub cut ane ously. 
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Table XIII: Skin reactions in rabbits protected with cell walls of 
Corynebacterium diphtheriae mitis strains 6823 (toxigenic) or 6795 
(nontoxigenic) or with Formol Toxoid, and challenged 30 days after 
the primary injection by intradermal inoculation of toxigenic 
Corynebacterium diphtheriae mltis strain 6823» 
Rabbit 
No. 
Immunizing 
antigen 
48-hour cutaneous reactions in mm at 
dose, xlÔ  v.u. 
indicated 
46 23 11.5 5.75 2.88 1.44 0.72 
1630 6823 CoW.̂ - 5x6 
0.4 
5x4 
0.2 
flo - - - — 
1632 It  9x10 
0.8 
8x8 
0.7 
5x6 
0.3 
fl. - - -
1635 It  7x7 
0,5 
5x5 
0.3 
fl. - - - -
1625 6795 c.wo* 11x11 
0.9 
8x9 
0.7 
6x6 
0.4 
fl. - - — 
1626 I I  8x8 
0,6 
6x7 
0.3 
fl. — - -
1628 I I  8x7 
0.5 
7x7 
0.5 
6x7 
0.4 
6x5 
0.3 
fl. - — 
1591 Toxoid")̂  fl. fl. - - — — -
1592 I I  fl. fl. fl. fl. — — -
1593 I I  fl. — - - - -
1595 Control 15x18 
2,0 
13x15 
1.4 
9x10 
0,9 
7x7 
0.7 
6x5 
0.4 
fl. — 
1596 I I  16x17 
1.7 
12x14 
1.1 
10x12 
0.9 
8x9 
0.6 
6x7 
0.5 
fl. 
1597 I I  18x20 
1.8 
15x16 
1.4 
14x11 
1.0 
8x7 
0.7 
5x4 
0.4 
fl. -
Immunizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
Human dose, 50 Formol Toxoid given subcutaneously. 
Table XIV: Skin reactions in rabbits protected with cell walls of 
Corynebacterlim dit̂ htheriae mitis strains 6823 (toxigenic) or 6795 
(nontoxigenic)or with Formol Toxoid and challenged 30 days after 
the primary injection by intradermal inoculation of toxigenic 
Corynebacteriiim diphtheriae gravis strain 606l. 
Rabbit 
No. 
Immunizing 
antigen 
48-hour cutaneous reactions in mm at indicated 
dose, xlÔ  viable units 
54 27 13.5 6.8 3.4 1.7 0.85 
1630 6823 c.w,* 14x15 
1.4 
11x13 
1.1 
8x10 
0,8 
7x6 
0.4 
4x5 
0.3 
fl. — 
1632 ÎÎ 15x13 
1.3 
14x11 
0,9 
10x10 
0.6 
6x5 
0.4 
fl. — -
1635 H 10x11 
0.7 
8x9 
0.5 
6x7 
0.4 
5x5 
0,2 
fl. — — 
1625 6795 c.w.î  21x17 
2,4 
l6xl6 
1,8 
13x10 
1.1 
8x9 
0.7 
6x7 
0.5 
fl. — 
1626 Î Î  15x18 
1.6 
12x13 
1,1 
8x11 
0,8 
7x7 
0.5 
fl. - — 
1628 I Î  14x16 
1.7 
12x13 
1.4 
9x11 
1.2 
6x8 
0.7 
4x5 
0.3 
fl. — 
1591 Toxoid"̂  ̂ fl. fl. fl. — -
1592 I I  8x7 
0.3 
6x5 
0.2 
fl. fl. — — — 
1593 tf fl. fl. — — — — 
1595 Controls 25x27 
3.2 
17x19 
2,1 
15x16 
1,5 
12x11 
0,9 
9x9 
0,5 
5x7 
0.4 
fl. 
1596 I I  29x21 
2,7 
21x17 
1.8 
12x13 
1,2 
11x9 
0,9 
8x7 
0.5 
6x7 
0.4 
fl. 
1597 fî  22x19 
2.3 
17x14 
1,6 
15x11 
1,1 
10x10 
0,9 
9x6 
0.7 
5x4 
0.3 
fl. 
* Immunizing dose was 1.5 mg cell wall material (dry weight) 
given intravenously. 
•5H(- Human dose, 50 Formol Toxoid given subcutaneously. 
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of rabbit 1629) 2 to 16 times more organisms were required to produce 
a lesion than in the control animals. The immunized animals were able 
to control the infection more satisfactorily since the intensity of the 
reaction to the same dose was more pronounced in the controls. Of the 
two groups, those immunized with cell walls of the toxigenic mitis strain 
were protected more favorably than the animals receiving nontoxigenic mitis 
cell walls. The data also show that the mitis cell wall antigens im­
munize somewhat more effectively against the mitis challenge than against 
the gravis or intermedius challenge. 
That the resistance afforded rabbits immunized with cell walls was 
not due to the presence of detectable antitoxin is illustrated by positive 
Schick tests (Table XV), negative flocculation reactions, and negative 
tests for determination of antitoxin at the 0.001 level. Moreover, none 
of the rabbits immunized with cell walls or with FT reacted to 50x10̂  
heat-killed toxigenic mitis (Table X?) indicating that delayed reactions 
probably had little to do with the test. 
Examination of the serum agglutinin titers (Table XVl) shows that 
cell wall antigens administered in increasing doses over a short time can 
effectively induce the formation of antibodies against all 3 toxigenic 
strains of the diphtheria bacilli. 
Experiment 5. Minimal lethal dose (MLD) in guinea pigs of toxigenic 
mitis» A suspension of viable diphtheriae mitis strain 6823 was pre­
pared in the usual manner. This suspension was diluted over a wide range 
of turbidity readings on the colorimeter and plated on serum tellurite 
medium. For each dilution, a single 8 to 10-week-old guinea pig was 
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Table XV; Skin reactions to Schick Test dose of diphtheria toxin and 
heat-killed Corynebacteriiim diphtheriae mitis strain 6823 in rabbits 
immunized with cell walls of Coimebacterium diphtheriae mitis strains 
6823 (toxigenic) or 6795 (nontoxigenic) or with Formol Toxoid. 
48-hour skin reactions in ma 
Rabbit Immunizing Schick Test Dose, 0,00004 Lf Heat-killed . 
No. antigen unhealed heated organisms 50x10 
1630 6823 C.Wo"^ 9x10x0.2 c 
1631 tî  12x12x0.3 
1632 tî  11x10x0.4 — 
1633 tî  9x11x0,3 «. 
1634 î î  9x10x0.4 - -
1635 tî  8x9x0.2 - — 
1624 6795 c.w,* 7x8x0,2 a» 
1625 î î  12x11x0.3 - a. 
1626 tî  9x10x0.3 — — 
1627 î î  8x11x0.2 -
1628 l î  13xll3d),4 -
1629 tî  11x10x004 — 
1588 Toxoid̂  «. «. 
1589 î î  - — -
1590 î î  
1591 fî  — a» 
1592 fî  o» — <» 
1593 î î  «-
1594 Control 9x8x0.2 — ». 
1595 î î  11x10x0.4 -
1596 fî  9x9x0.2 - — 
1597 fî  11x9x0.3 0» — 
1660 î î  10x10x0.3 a» 
1662 î î  10x12x0.2 » 
 ̂Immunizing dose was 1̂ 5 mg cell wall material (diy weight) 
given intravenously o 
Human dose, 50 Formol Toxoid given subcutaneously. 
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Table XVI; Serum agglutinin titers to heat-killed mitis 6823, gravis 
6061, and intermedins 6796 strains of Corynebacterium diphtheriae in 
rabbits immunized intravenously with cell walls of diphtheriae mitis 
6823 (toxigenic) and 6795 (nontoxigenic). 
serum 
no. 
immunizing 
antigen 
agglutinin titer to organisms diluted to 
francis std. 
mitis 6795 mitis 6823 gravis 606i intermedins 
1630 
1631 
1632 
1633 
1634 
1635 
6823 c.w. 
ii 
it 
it 
it 
it 
1280 
640 
320 
320 
640 
640 
5120 
2560 
2560 
2560 
5120 
2560 
1280 
640 
640 
640 
1280 
640 
640 
640 
320 
160 
320 
640 
1624 6795 c.w. 1280 2560 640 160 
1625 it 5120 2560 640 320 
1626 11 5120 2560 1280 640 
1627 ii 1280 1280 640 320 
1628 it 2560 1280 640 320 
1629 it 640 160 80 80 
-45-
injected intradermally with 0.2 ml of the suspension. Deaths were 
recorded daily. The data indicated that between 10x10̂  and 30x10̂  
viable organisms were required to kill a guinea pig in 4 days (1 MLD), 
When suspensions of organisms within this range were injected into guinea 
pigs on 3 separate occasions the results showed that 1 MLD was approx­
imately 21x10̂  organisms (Table XVII). This concentration, the lethal­
ity of which was verified on 5 additional guinea pigs (Table XVII, 
group D), was employed as 1 guinea pig MLD. 
Guinea pigs receiving doses of organisms above one MLD succumbed 
with characteristic symptoms of diphtheritic intoxication. Onset of 
illness was sudden followed by lethargy and death within minutes from 
what appeared to be acute respiratory or B̂ ocardial failure. The 
reactions at the site of inoculation of the toxigenic organisms were 
characteristically slight, with no marked edema. Guinea pigs injected 
with smaller concentrations of organisms were affected in a different 
manner. They became cachectic on the second or third day and remained 
in a quiescent condition toward the rear of the cage. On the third or 
fourth day paralysis of the hindquarters developed. If death super­
vened, intense dyspnea and convulsions were apparent, possibly being 
provoked by paralysis of the diaphragm. At this stage death was 
imminent. The local lesions in these animals were quite large and 
Mich more pronounced than in guinea pigs which expired rapidly. 
Experiment 6. Resistance of guinea pigs immunized with cell walls 
of toxigenic and nontoxigenie mitis. This experiment involved deter­
mining the efficacy of using cell walls as immunizing antigens in guinea 
Table X?II: Determination of the minimil lethal dose in guinea pigs to 
intradermal challenge with toxigenic Corynebacteriiun diphtheriae mitis 
strain 6823. 
Group 
Challenge 
dose# 
(0.2 ml) 
No, of 
guinea 
pigs 
Day of 
death 
Viable,count, 
xlÔ  
A KS 150 1 2 27.2 
KS 125 1 3 22.6 
KS 100 1 9 18.1 
KS 75 1 — 13.6 
KS 50 1 — 9.1 
B KS 150 1 3 26.6 
KS 125 1 h 22.2 
KS 100 1 10 17.7 
KS 75 1 - 13.3 
KS 50 1 — 8.7 
C KS 150 1 2 24.4 
KS 125 1 4 20.3 
KS 100 1 7 16.3 
KS 75 1 - 12.2 
KS 50 1 - 8.1 
No. dead on 
indicated day 
1 2 3 4 5  
D KS 125 5 — — 2 3 ~ 20.0 
'K- Adjusted with Klett-Summerson photoelectric colorimeter (KS) 
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pigs. For this piirpose the cell walls of the toxigenic and nontoxigenic 
strains of mitis were incorporated in Fretind's complete adjuvant. The 
adjuvant was prepared as described in Experiment 2. Guinea pigs, 4 
weeks old, were divided into 3 groups of 6 each. Group I received the 
cell walls of the toxigenic strain and group II received cell wall antigen 
of the nontoxigenic strain. The third group served as normal controls. 
Each animal in groups I and II received 4 subcutaneous injections of the 
respective antigen, one in each inguinal and axillary region. This 
amounted to one mg tubercle bacilli per injection site and a total of 
2 mg cell walls per animal. Booster injections were given subcutan-
eously in the nuchal region at the end of the third and fourth week. 
Each dose contained 0.5 mg of cell walls (dry weight) suspended in 0.5 
ml saline. 
One week after the final immunizing dose, all animals were Schick 
tested and challenged intradermally with 1.5 MLD's of toxigenic diph-
theriae mitis strain 6823. The results are shown in Table XVIII and 
seem to support the data obtained from the previous studies with rabbits. 
Cell walls derived from either toxigenic or nontoxigenic mitis can serve 
as immunizing antigens against challenge with toxigenic mitis. A compar­
ison of the effectiveness of the cell wall antigens is given in Fig. 3. 
The results taken when 50̂  of the animals in each group were dead show 
that guinea pigs immunized with cell walls of the nontoxigenic strain 
were approximately 2 times more resistant than the controls. The animals 
protected with cell walls of the toxigenic strain were about 4 times more 
resistant. Moreover, one-half of the guinea pigs in the latter group 
survived the total effects of the challenge dose and appeared normal at 
Table X7III; Protection of guinea pigs against intradermal challenge with toxigenic Corynebacterium 
diphtherlae mitis 6823 by subcutaneous immunization with cell walls of Corynebacterium diphtheriae 
mitis strains 6823 (toxigenic) or 6795 (nontoxigenic). 
Group Immunizing antigen 
No. of 
guinea 
pigs 
Challenge 
dose 
(MLD) 
No. dying on indicated day Total survivors/ 
Total dead 
1 2 3 4 5 6 7 8 14 
I 6823 Ç.W.* 6 1.5** — — - — o/i § 1 /1 — — - 3/3 
II 6795 c.w. 6 1.5 — — 1/3 1/0 i/o 0/6 
III Control 6 1.5 - 3/3 0/6 
* Immunizing dose was 3 mg cell wall material (dry weight) given subcutaneously. 
n 
** Challenge dose (0,2cc) consisted of 3.0 x 10 viable units. 
S No, of guinea pigs dying in first 12 hrs./no of guinea pigs dying in second 12 hrs. 
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Figure 3î Immunizing effect of toxigenic and nontoxlgenic mitis cell 
walls against challenge with 1.5 MLD's. 
A ĝuinea Digs (6) immunized c toxigenic c.w, 
g ©guinea pigs (6) immunized c nontoxlgenic c.w. 
• controls 
100 
75 
50 
25 
Days after challenge 
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14 days. No sign of postdiphtheritic paralysis was observed up to the 
thirtieth day when the animals were discarded. 
The inoculation site in the control animals was characterized by a 
nonedematous, diffuse reaction. In sharp contrast, both groups of 
immunized guinea pigs developed large, well-demarcated lesions indicating 
an attempt by the animal's defense mechanism to counteract the infective 
process. 
All the guinea pigs were Schick test positive on the day after 
challenge, indicating that resistance was not due to the presence of 
detectable antitoxin. 
Experiment 7. Protective effect of toxigenic mitis cell wall antigen. 
The degree of resistance to various lethal doses of toxigenic organisms 
was examined. Twenty-four guinea pigs were divided equally into 4 
groups. The first 3 groups were immunized with cell walls of the toxi­
genic mitis strain in Freund's complete adjuvant as described in the 
previous experiment. Each animal received 2 mg cell walls in adjuvant 
as the primary stimulus and 1 mg as the secondary stimulus. Group IV 
received a human dose of FT (50 L̂ ). 
One week after receiving the last immunizing dose of antigen, 
the animals were Schick tested and challenged with the toxigenic strain 
of mitis according to the protocol in Table XIX. The results indicate 
that cell wall immunization completely protected against 1 MLD (group l), 
Althoû  the immunized guinea pigs in this group developed large necrotic 
lesions at the site of the inoculation of the toxigenic culture, there 
was no evidence of intoxication or cachexia, and all animals remained 
Table XIXs Protection of guinea pigs against intradermal challenge with 1, 2, and 4 MLD's of toxigenic 
Corynebacterium diohtheriae mitis strain 6823 by subcutaneous iiranunization with cell walls of C, diphtheidae 
mitis strain 6823 or with Formol Toxoid. 
Group Immunizing antigen 
Ho. of 
guinea 
pigs 
Challenge 
dose 
(MLD) 
No. dying on indicated day Survivors/ 
Total dead 
1 2 3 4 5 6 7 8  1 4  
I 6823 C.W.* 6 1 6/6 
II It 6 2 — — — 0/3 §1/1 — 1 /o 0/6 
III II 6 4 - 0/5 - 1/0 0/6 
1 
IV Toxoid#-* 6 2 
vn 
6/6 Y 
V Control 6 1 - 0/2 2/2 0/6 
VI IÎ 6 2 - 0/5 1/0 0/6 
VII n 5 4 - 5/0 0/6 
* Immunizing dose was 3 mg cell wall material (dry weight) given subcutaneously. 
Human dose, 50 given subcutaneously. 
§ No. of guinea pigs dying in first 12 hrs./no. dying in second 12 hrs. 
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healthy. The challenge dose produced only local reactions comparable 
to those in normal guinea pigs infected with a sublethal dose of C. 
diphtheriae. The protection against 2 MLD's of organisas (group II) 
was considerably less since none of the experimental animals survived 
the challenge. A comparison of the 50̂  survival times (Fig. 4) shows 
that the immunized guinea pigs survived 4 days while the controls 
(group VI) only lived 1.25 days, indicating that the experimental animals 
were about 3 times more resistant. Moreover, the experimental animals 
did not succumb from rapid intoxication as did the controls, but from 
slow paralysis indicating some ability on behalf of the immunized guinea 
pigs to control the infection. It is interesting to note that guinea 
pigs immunized with a human dose of FT (group IV) survived 2 MLD's of 
the toxigenic mitis strain, suffering no ill effects other than a mod­
erate reaction at the site of inoculation. 
Immunized guinea pigs were not protected against challenge with 4 
lethal doses of organisms (group III). None of the immunized animals 
survived beyond the third day, although all of them lived longer than 
the controls challenged with the same dose. At most, the animals pro­
tected with cell wall antigens were 1.6 times more resistant than the 
controls (Fig. 4). 
With the exception of the guinea pigs vaccinated with FT, all the 
experimental and control animals were Schick positive on the day of 
challenge, indicating that resistance was not due to the presence of 
detectable antitoxin. 
Experiment 8. Immunogenicity of cell walls suspended in adjuvant 
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Figure k' Immunizing effect of toxigenic mitis cell walls against 
challenge with 2 and 4 MLD's. 
guinea pigs (5) control, challenged 5 4 MLD's 
guinea pigs (6) immunized, challenged c 4 MLD's 
guinea pigs (6) control, challenged 2 MLD's 
guinea pigs (6) immunized, challenged c 2 MLD's 
100 -
1 0) 
Ti 
6 7 3 5 4 2 
Days after challenge 
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or saline. Nonnal guinea pigs, 3- to 4-weeks-old, were divided into 
4 groups of 6 each and immunized with cell walls prepared from C. 
diphtheriae mitis strain 6823. The animals in group I were each immun­
ized with 3 rag of cell wall material incorporated in Freund's adjuvant 
(Experiment 2). Group II received a similar preparation except the adju­
vant was void of tubercle bacilli (Freund's incomplete adjuvant). Group 
III was administered a single dose of 3 mg of cell walls suspended in 
sterile physiological saline (SS). The animals in group IV were immunized 
with 2 doses of cell walls (1.5 mg each) in SS spaced 3 weeks apart. All 
the antigen mixtures were injected subcutaneously and distributed equally 
in each inguinal and axillary lymph node region. In addition to the guinea 
pigs immunized with cell walls, 2 other groups were used. The 6 guinea 
pigs comprising group V were given a human dose of FT (50 L̂ ). The sixth 
group served as normal controls. 
Data presented in Table XX show that the immunogenicity of the cell 
wall antigen was enhanced by the presence of the oil in Freund's adjuvant. 
However, comparable protection was obtained when oil was not used and 
the antigen was inoculated in two separate doses (group IV) indicating 
that resistance to 1 MUD of C_. diphtheriae can be obtained without the 
use of an adjuvant. The degree of non-specific resistance due to the 
tubercle bacilli cannot be determined from this experiment, although 
other experiments may reveal the participation of non-specific factors. 
Ejqjeriment 9. Survival of C. diphtheriae in spleens of immunized 
guinea pigs. During one phase of the guinea pig protection experiments, 
spleens of immunized animals that had been challenged intravenously with 
Table XX; Protection of guinea pigs immunized subcutaneously with cell walls of Corynebacterium 
diphtheriae mitis strain 6823 and challenged intradermally 28 days after primary injection with 
1 MLD of toxigenic Ç. diphtheriae mitis strain 6823. 
No. of 
guinea 
pigs 
Immunizing 
antigen 
Immunizing 
dose 
(subcut.) 
No. dying on indicated day 
5 8 10 11 20 
Survivors/ 
total tested 
6 
6 
6 
6 
cell walls in 
Ft eund's complete 
adjuvant 
cell walls in 
Freund's incomplete 
adjuvant 
cell walls in 
saline 
cell walls in 
saline 
Toxoid 
Control 
3 mg. 
3 mg. 
3 mg. 
1.5 mg.̂  
1.5 mg.' 
50 
1 1 
- - 2 3  
6/6 
6/6 
3/6 
5/6 
6/6 
0/6 
& 
vn 
f 
 ̂Separated by 3 weeks# 
—$6— 
toxigenic organisms were cultured (Larson and Wicht, 1962). Subsequently 
5 guinea pigs were immunized in the conventional manner with cell walls 
of the toxigenic mitis strain of diphtheriae emulsified in Freund's 
complete adjuvant. Ten days after immunization, the experimental and 4 
control animals were inoculated intravenously with 80x10̂  toxigenic C. 
diphtheriae mitis. After 24 hours the animals were sacrificed and 
autopsied. Each spleen was removed aseptically, weighed, and diluted 
1:10 in casamino acid diluent. The organ was then ground for 1 minute 
with a Teflon grinding apparatus and serial 10-fold dilutions were made in 
the same diluent. Selected dilutions in 0.1 ml quantities were plated in 
duplicate and allowed to incubate for 2 to 3 days at 34 C, after which time 
the colonies were counted. A comparison of the number of viable organisms 
recovered from immunized and normal animals is shown in Table XXI. 
Guinea pigs protected by cell wall immunization demonstrated marked 
ability to control the multiplication of toxigenic mitis in the spleen. 
The data show that an average of 1573 viable organisms were recovered 
from spleens of the control animals, whereas not a single spleen culture 
from the immunized group was positive, indicating greater than a 1000-
fold difference. This result implies that the protection afforded guinea 
pigs immunized with cell walls might be greater than that indicated by 
the data obtained from the previous experiments. 
Experiment 10. Lethality of protoplasmic fraction. During the 
course of the guinea pig eaperiments, normal animals were injected with 
protoplasm obtained from 1, 4> and 10 MID's of toxigenic organisms in 
order to determine if the lethal effect of 20x10̂  organisms (l MID) was 
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Table XXI: Survival of toxigenic Corynebacterixim diphtheriae mitis 
strain 6823 in the spleens of guinea pigs immunized with cell walls of 
C orynebacterium diphtheriae mitis strain 6823. 
Animal No. Immunizing antigen Viable cell count̂ H:-
in spleens 
1 
2 
3 
4 
5 
6 
7 
8 
9 
6823 c.w.* 
Control 
average 
1573 
•5̂  Immunizing dose was 3 mg cell wall material given subcutaneously. 
•5̂ 5̂  Results obtained 24 hours after intravenous challenge with 
80x10̂  v.u./dose. 
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due to the toxin contained in the protoplasm of that number of organisms 
or was due to proliferation of organisms and subsequent release of toxin. 
Accordingly dibhtheriae mitis strain 6823 was prepared in the usual 
manner for procuring challenge doses. The equivalent of 100 MLD's 
(2000x10 organisms) was suspended in Moloney buffer and disrupted in 
the Hickle tissue disintegrator. The protoplasm (supernatant) was 
separated from the cell walls by high-speed differential centrif ugation. 
Preparations containing any visible cell fragments were discarded. Since 
the protoplasm was obtained from 2000x10̂  organisms, and 20x10̂  organisms 
constitutes 1 MLD, it was possible to estimate the amount of protoplasm 
contained in 20x10̂  bacilli by diluting the supernatant 100-fold. 
Similarly the protoplasm from 80x10̂  organisms (4 MLD's) was obtained 
by diluting the original supernatant 25-fold. All dilutions were made 
in Moloney's buffer. Each dilution was injected intradermally into 4 
normal guinea pigs and the deaths were recorded daily. 
Data presented in Table XXII show that only those guinea pigs 
receiving protoplasm obtained from 4 and 10 MLD's of toxigenic mitis 
organisms suffered a mortality rate not too different from the animals 
injected with live organisms. Guinea pigs inoculated with protoplasm 
from 1 MLD of organisms lived, although all manifested symptoms of 
diphtheritic intoxication. When heat-sterilized cell walls were added 
to 2 of the protoplasmic fractions, the mortality rate of the guinea pigs 
receiving the equivalent of 4 MLD's of protoplasm and cell walls was 
nearly the same as the group challenged with 1 MLD of virulent organisms. 
Those receiving protoplasm from 1 MLD of organisms and cell walls lived, 
albeit with large necrotic dermal lesions at the injection site. A 
Table XXIIs Susceptibility of guinea pigs to the protoplasmic fraction obtained from toxigenic 
Corynebacterium diphtheriae mitis strain 6823. 
Group 
No. of 
guinea 
pigs 
Protoplasm 
from No. dying on indicated day Survivors/ 
total tested (0.2 ml) 1 2 3 4 5 6 7 8 9  
I 4 10 MLD's — — — " 12 1 0/4 
II 4 4 MLD's - - - - - -  1  1 2  0/4 
III 4 1 MLD's 4/4 
IV* 3 
4 MLD's 
+ 
cell walls 
0/3 
V# 3 
1 MLD 
+ 
cell walls 
3/3 
VI 6 1 MLD live organisms - - 2 3 1 0/6 
* Same as groups II and III except the suspension also contained heat sterilized cell walls 
from 4 and 1 MLD, respectively, of C. diphtheriae mitis strain 6823. 
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similar study involving heat-killed (58 C for 10 min) whole virulent C. 
diphtheriae mitis strain 6823 in equivalent challenge doses of 1, 2, and 
4 MLD's proved even less successful. Although all the test animals 
developed dermal necrotic lesions, they were not as large as the reactions 
on the guinea pigs in Table XXII and none of the doses were fatal. However, 
both of these methods for examining the toxin production by a certain 
number of cells only consider the toxin content of the cells at a given 
time. In the actual challenge with living organisms, toxin production 
is a dynamic process, rather than a static one, and is much more marked 
during induced lysis (Barksdale, Garmise, and Rivera, 1961). 
Experiment 11. Production of "natural" diphtheria in guinea pigs. 
Since the data in Table XXII indicated that death by intradermal challenge 
did not involve an infectious process like that occurring in man, other 
methods of challenge were tried. Repeated attempts (Roux and Yersin, 
1888; Loeffler, 1884) to produce a diphtheritic membrane in guinea pigs 
by first excoriating the superficial epithelium of the eye or trachea 
and then daubing these areas with a pure culture of toxigenic organisms 
were of little success. Occasionally, guinea pigs receiving a massive 
quantity of organisms (>10® toxigenic organisms) suffered clinical 
syndromes of diphtheritic intoxication terminating in death. A similar 
procedure involving a few rabbits yielded the same results. Another 
technique used by Scheibel (1950) to establish a cutaneous focus of 
infection on the ventral wall of the animals also failed to demonstrate 
a pattern of pathogenesis similar to diphtheria in man. Partial success 
was achieved, however, when the method of Loeffler (I884) and Cruveilhier 
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(1911) was used. By applying a virulent broth culture onto a mechanically 
ruptured hymen, most of the guinea pigs could be shown to develop vulval 
diphtheria with typical membrane formation and a slight amount of inflam­
mation. Although, none of the guinea pigs succumbed as a result of the 
disease, which usually cleared up in 4 to 6 days, immunization studies 
could be performed using the development of vulval diphtheria as a test 
for resistance. However, this would necessitate the use of large numbers 
or experimental animals, a situation impractical in this study. 
CHAPTER ? 
DISCUSSION 
Previous studies on development of resistance to diphtheria have 
centered around the use of classical diphtheria toxoid rather than 
bacterial vaccines as immunizing agents. In view of the success of 
Larson and his associates (Larson et al., 1963; Eibi et al., 1966) 
in protecting mice by immunization with cell wall antigens against 
infection with Mycobacterium tuberculosis, it was thought possible 
to actively immunize guinea pigs and rabbits against experimental diph­
theria with cell walls of Corynebacterlum diphtheriae. 
The concept was that by inducing only an antibacterial response, 
the immune animals would upon subsequent contact with virulent organisms 
react by eliminating the organisms, preventing an infectious process from 
becoming established, and thus make it impossible for sufficient toxin to 
be produced to lead to illness. On a broader scope, children protected 
by antibacterial resistance and later infected with a virulent strain of 
the diphtheria bacillus would either destroy the organisms immediately 
or would enjoy exceedingly low morbidity rates in the process of becoming 
increasingly resistant. The latter implies a minor clinical infection 
developing in the nasal-pharyngeal region due to a slow anemnestic 
response on the part of the host or because of a delayed migration of 
antibody-producing cells to the infection focus. As a result, a small 
number of organisms would multiply and secrete toxin into the surrounding 
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epithelial tissue until such time that sufficient irritation caused the 
stimulation of a minor inflammatory reaction. The subsequent release of 
humoral and cellular resistance factors from the blood vascular system 
would provide the necessary defense to destroy further proliferation of 
the organisms. In the instance of a slowly developing inflammatory 
response, the continued release of toxin into the neighboring tissue by 
a small number of organisms could initiate an antitoxic response leading 
to a Schick negative condition in the host. 
To test the general hypothesis of antibacterial resistance to 
diphtheria, rabbits and guinea pigs were immunized with cell walls 
prepared from the mitis strain of diphtheriae. This strain was chosen 
since it is reportedly the least virulent of the diphtheriae strains 
(Cooper, Happold, and McLeod, 1936; McLeod, 1943) and would thus be the 
strain least likely to cause a reaction in the host during immunization. 
Dubos (1949) has questioned whether or not a virulent strain of organ­
isms is preferable to a less virulent one for production of non-living 
vaccines. 
Preliminary studies in this investigation show that rabbits immun­
ized with cell walls of virulent and avirulent diphtheria bacilli develop 
resistance to intradermal infection with virulent diphtheria bacilli. 
This resistance is demonstrated by the ability of immunized animals 
to tolerate from 2 to l6 times more organisms than non-immunized controls 
and by the increased capacity of immune animals to control the infectious 
process caused by larger numbers of virulent organisms. The immune 
response is probably not associated with delayed hypersensitivity or 
dependent upon the ability of the host to localize or bind toxin at 
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the initial focus of infection (Frobisher and Parsons, 1943» Frobisher 
and Updyke, 1947), but is due to an enhanced humoral response directed 
specifically against the bacterial cells themselves. This is supported 
by the appearance of agglutinating antibodies in the blood stream, by 
the correlation between the in vivo and 3̂  vitro neutralization to 
toxigenic activity, by the inability of toxigenic organisms to survive 
in the spleen, and by the lack of any measurable antitoxic response 
in rabbits injected with cell wall antigens, a fact also noted by 
Frobisher (Frobisher and Parsons, 1950) and Scheibel (1950). 
The route of inoculation does not appear to be as critical as the 
administration of a second dose of cell wall antigens. Both the intra­
venous and subcutaneous routes serve about equally well as routes for 
injection of the antigen, although the agglutination titers are somewhat 
higher in rabbits inoculated subcutaneously. In the latter case the 
immune response is undoubtedly enhanced by the adjuvant effect of mineral 
oil and tubercle bacilli in Freund's complete adjuvant. These sub­
stances are known to stimulate increased antibody response by permitting 
the slow release of antigen and permitting a focus for antibody release 
(Humphrey and White, I964). 
Resistance afforded rabbits immunized with cell walls of the mitis 
strains of diphtheriae is more pronounced against homologous challenge 
than against heterologous challenge with the toxigenic gravis and inter-
medius strains. Similar observations were made by Frobisher and Parsons 
(1950) and by Bowan, Wyman, and McComb (1954). This correlates with the 
humoral response against the three different strains (Figure 2 and Table 
XVII) and reflects their antigenic differences. It also shows that the 
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immune response in animals receiving cell wall preparations is directed 
toward the organisms per se and not against the exotoxin as Frobisher 
has proposed (Frobisher and Parsons, 1950), If the latter were the case, 
all animals receiving cellular vaccines from one strain would react 
equally against challenge by any one of the strains. Moreover, one would 
be inclined to assume that the toxin elaborated by the 3 strains would 
be antigenicaHy different, a point refuted by existing evidence (for 
references, see Zinnemann, 1943)« 
The fact that immunization with cell walls of the toxigenic mitis 
strain confers greater protection than cell walls of the nontoxigenic 
strain of mitis can be explained by antigenic dissimilarities within the 
strain. Similar data has been shown with smooth (virulent) and rough 
(avirulent) strains of Salmonella typhi which have been shown to possess 
different antigenic properties when examined by agar gel diffusion 
techniques (Pigeon et al,, 1965)» 
The current studies with guinea pigs show that they can be immunized 
with cell wall antigens of diphtheriae mitis strain 6823, Complete 
protection is afforded against the lethal effect of 1 MLD (20x10̂  
viable units) of the toxigenic mitis. Immunized guinea pigs develop 
partial resistance to 1,5 and 2 MID's and almost no immunity to 4 MLD's, 
The absence of a detectable antitoxic response is inferred from the data 
presented in the experiments on rabbits (the ceU walls were prepared in 
the same fashion) and shown by positive Schick reactions in guinea pigs 
at the time of challenge. 
The inability of cell wall vaccines prepared from the nontoxigenic 
mitis to elicit an immune response as efficient as that from cell walls 
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of the toxigenic mitis strains appears to reflect differences in antigenic 
composition between the strains. Since neither group of experimental 
animals, and especially those receiving toxigenic mitis cell walls, 
demonstrate an anti-toxic response, the mechanism of resistance cannot 
be associated with toxin neutrailzation. 
The addition of adjuvants to the cell walls enhances the imrauno-
genicity of these preparations. Adjuvants of this type seem to provide 
a prolonged antigenic stimulus, a depot in the tissues in the form of a 
granulomatous lesion which permits the slow and continuous release of 
antigen, and a stimulus to the antibody-producing cells in the vicinity 
(Wilson and Miles, 1964). Guinea pigs receiving Freund's adjuvant 
(complete or incomplete) are able to withstand the lethal effects of 1 MLD 
of viable organisms whereas guinea pigs receiving cell walls suspended 
in saline are not protected to the same extent. However, it is note­
worthy that cell walls suspended in saline and introduced subcutaneously 
induce a favorable immune response in guinea pigs. This means that cell 
walls themselves, divorced from an adjuvant, can serve as effective 
immunizing agents. 
The absence of virulent mitis organisms in the spleens of guinea 
pigs immunized with cell walls lends further support to the existing 
data. It is regretable that a third group consisting of animals vac­
cinated with diphtheria toxoid was not included, as this would aid in 
giving a comparison between the relative merits of toxoid and cell wall 
antigens, Hypothetically, at least, the number of organisms recovered 
from spleens of toxoid imiminized animals would vary little from the number 
recovered from the controls, since the response induced by the toxoid 
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would be directed against elaborated toxin and not against the organism. 
That toxoid immunization evokes a purely antitoxic response is substan­
tiated by the work of Huang (1942). 
During this phase of the research the importance of the protoplasmic 
fraction of toxigenic C_j_ diphtheriae mitis was fully realized. The reali­
zation was that such large numbers of toxigenic organisms were required 
to produce a lethal infection in guinea pigs that antibacterial immunity 
could play only a very restricted role in prevention of deaths due to 
toxin. If the lethal effect due to 1 BID of toxin is contained in 
fewer than 8 to 16 times the number of viable units required to infect 
guinea pigs, it is difficult to visualize how antibacterial immunity 
could be effective. The effect of antibacterial immunity in prevention 
of death among mice infected with plague bacilli is evident from Larson's 
studies (unpublished data). Mice succumb to plague toxin elaborated 
during the course of infection, but infection can be initiated by only 
a few plague bacilli which then proliferate through many generations to 
produce sufficient toxin. With systems represented by diphtheriae 
and guinea pigs it is evident that proliferation of organisms was not too 
great a factor in production of lethal disease. These ideas were strength­
ened by belated examination of a report by Roux and Tersin (1888) in 
which they noted the failure of toxigenic diphtheria to proliferate to 
any extent when injected into the cutaneous tissues of guinea pigs. 
Our tests of the lethal effect of protoplasm in guinea pigs show 
that the protoplasm of 4 MLD's of viable toxigenic organisms is approx­
imately equal to 1 MID of living organisms in producing lethal effects. 
This small discrepancy between results obtained with protoplasm and with 
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viable bacilli may result from detoxification during cell disruption and 
the time required to harvest and inject protoplasm into the guinea pigs. 
However, as mentioned in the previous section, toxinogenesis is a dynamic 
process; at a given time cells do not contain all the toxin they are 
capable of producing (Barksdale et al,, 1961). Moreover, Pappenheimer 
and Yoneda (1957) have shown that 20x10̂  toxigenic mitis organisms 
(a lysogenic mitis) produce on the order of 0.03 Lf toxin protein, and 
there is evidence that differences in toxinogenicity between individual 
virulent strains is not very wide (Hswlitt, 1948). Since approximately 
0.020 Lf toxin protein constitutes 1 MLD of organisms (Wilson and Miles, 
1964), the infective dose of 20x10̂  toxigenic mitis organisms, or 1 MLD 
as used in this study, is capable of producing sufficient toxin to kill 
normal guinea pigs in 3 to 4 days. Even though this is an a priori 
argument, the evidence indicates that the intradermal challenge system 
used in this study was adapted primarily to studies of antitoxic resist­
ance and could be expected to show antibacterial immunity only if 
resistance was of high magnitude. It appears from these studies that the 
antibacterial resistance produced with cell walls limited growth of the 
infective dose of toxigenic organisms since 1 MID of toxigenic bacilli 
did not produce death. In spite of the artificiality of the challenge 
system, it is interesting to note that we were able to produce resistance 
to 1 and 2 MLD's of toxigenic mitis organisms. Previous workers were 
unable to achieve protection of this type. This suggests that with a 
natural route of infection in a natural host where proliferation of 
organisms occurs, the efficacy of cell wall immunization might be much 
more pronounced than is indicated in this study. 
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Attempts to discover a natural route of infection in guinea pigs 
(and to a limited extent in rabbits) for which relatively few organisms 
would produce a clinical disease were largely unsuccessful. The work of 
Loeffler (1884) and Eoux and Yersin (1888) indicated that slight trauma to 
certain mucous membranes or the cornea in guinea pigs, pigeons, cats, dogs, 
rabbits, and monkeys followed by inoculation of the area with large numbers 
of organisms in a broth culture sometimes produced a typical diphtheritic 
membrane and death. The only method found to be slightly successful was 
inoculation of the vulval area of guinea pigs after the hymen had been 
ruptured mechanically (Loeffler, 1884). Results were inconsistent and 
variable. Whether the mitis strain loses its infectivity after primary 
isolation as does Bordetella pertussis (Leslie and Gardner, 1931) was 
not determined. The most likely answer is that guinea pigs and rabbits, 
and probably the other animals tested by Loeffler and Roux and Yerson, are 
unnatural hosts, and that diphtheriae is a natural pathogen only for 
man. If one accepts this conclusion, it seems hardly likely that one 
could accurately test the efficacy of an inrnninlzing antigen in an 
artificial host. Therefore, in order to determine the actual value 
of cell wall antigens of diphtheriae, it would be necessary to test the 
preparations in man. 
CHAPTER VI 
SUMMARY 
1. Attenpts were made to induce active antibacterial resistance in 
rabbits and guinea pigs against diphtheria by immunization with 
cell walls of the mitis strain of C orynebacteritan diphtheriae. 
2. Rabbits immunized with cell walls of either the toxigenic or 
atoxigenic mitis strain of diphtheriae were shown to be protected 
against subsequent intradermal infection with sublethal doses of 
toxigenic diphtheria bacilli. 
3. Resistance afforded rabbits imminized with cell walls of the mitis 
strains is more pronounced against homologous challenge than against 
heterologous challenge with the toxigenic gravis and intermedius 
strain. 
4. Antibacterial sera prepared in rabbits immunized with cell walls of 
the toxigenic mitis is capable of neutralizing vitro the toxino-
genicity of diphtheriae mitis. 
5. Guinea pigs immunized with cell wall antigens of the toxigenic mitis 
in Freund's complete adjuvant demonstrated complete resistance to the 
lethal effects of 1 MLD, partial resistance to 1„5 and 2 MLD's, 
and no protection to 4 MLD's of toxigenic mitis organism, 
6. Cell walls emulsified in Freund's adjuvant (complete or incomplete) 
offered greater protection than cell walls suspended in saline, when 
both preparations were administered in a single dose. A saline 
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suspension of cell walls injected in 2 separate doses provided 
immunity comparable to that obtained with a single dose of cell 
walls in Freund's adjuvant. 
7. The resistance to infection with toxigenic diphtheria bacilli in 
guinea pigs and rabbits immunized with cell wall antigens is shown 
not to be associated with the presence of demonstrable antitoxin. 
8. The failure of inducing antibacterial immunity in laboratory animals 
is discussed in terms of the inability of toxigenic organisms to 
proliferate in the cutaneous tissues of the host. 
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